EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Prosthesis–Patient Mismatch and Patient-Centered Outcomes After TAVR

Ottavia Cozzi, Daijiro Tomii, Jonas Lanz, Holger Thiele, Dik Heg, Michael Joner, Helge Möllmann, Axel Linke, Lenard Conradi, Stefan Toggweiler, Christian Thilo, Bernard Prendergast und 3 weitere

JACC: Cardiovascular Interventions · 2026-11 · 19 (21) · 2857-2871

DOI: 10.1016/j.jcin.2026.07.049 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2026-11. Verfasst von Ottavia Cozzi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland; Cardio Center, IRCCS Humanitas Research Hospi…. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Aortic Valve Stenosis, Aortic Valve, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement has been widely studied for its association with clinical outcomes, but its effect on patient-reported health status remains less defined. OBJECTIVES: This study sought to evaluate the association between PPM severity and health status through 3-year follow-up after transcatheter aortic valve replacement. METHODS: This post hoc analysis of the SCOPE I (Safety and Efficacy of the ACURATE Neo/TF Compared to the SAPIEN 3 Bioprosthesis) randomized trial categorized patients according to PPM severity using Valve Academic Research Consortium-3 criteria. Endpoints included survival and patient-reported health status, with an integrated outcome defined as being alive with good health status (Kansas City Cardiomyopathy Questionnaire Overall Summary score ≥75 without a decline of >10 points from baseline). RESULTS: Among 662 patients, moderate and severe PPM occurred in 184 (27.8%) and 69 (10.4%), respectively. All-cause mortality at 1 and 3 years was 7.0% and 20.5%, with no differences across PPM categories. Kansas City Cardiomyopathy Questionnaire Overall Summary score was similar through 1 year but lower at 3 years in patients with severe vs no PPM (median 71.1 vs 83.9; P = 0.027). Fewer patients with severe PPM were alive with good health status at 3 years (30.6% vs 49.4%; P = 0.021). In multivariable analysis, severe PPM was associated with a lower likelihood of the integrated outcome (OR: 0.51; 95% CI: 0.27-0.96; P = 0.036), but this association was no longer statistically significant after adjustment for 30-day mitral regurgitation (OR: 0.59; 95% CI: 0.30-1.15; P = 0.121). CONCLUSIONS: Among survivors, severe PPM was associated with a lower likelihood of good health status at 3 years. This association was attenuated after accounting for 30-day residual mitral regurgitation, suggesting a possible contributory role. Given the post hoc design, the findings are hypothesis-generating.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisAortic Valve StenosisAortic ValveTranscatheter Aortic Valve ReplacementBioprosthesisPatient Reported Outcome MeasuresHumansTreatment OutcomeTime FactorsFemaleProsthesis DesignMaleAgedHealth StatusRisk FactorsSeverity of Illness IndexAged, 80 and overRecovery of Function

Stichwörter der Autor:innen

Kansas City Cardiomyopathy Questionnaire scoreprosthesis–patient mismatchtranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland; Cardio Center, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.
  • Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
  • Heart Centre Leipzig at Leipzig University, Leipzig, Germany.
  • Department of Clinical Research, University of Bern, Bern, Switzerland.
  • German Heart Centre, Technical University of Munich, Munich, Germany.
  • Department of Internal Medicine I, St-Johannes-Hospital, Dortmund, Germany.

Zitieren

APA

Cozzi, O., Tomii, D., Lanz, J., Thiele, H., Heg, D., Joner, M., Möllmann, H., Linke, A., Conradi, L., Toggweiler, S., Thilo, C., Prendergast, B., Windecker, S., Pilgrim, T., & SCOPE I Investigators (2026). Prosthesis–Patient Mismatch and Patient-Centered Outcomes After TAVR. JACC: Cardiovascular Interventions, 19(21), 2857-2871. https://doi.org/10.1016/j.jcin.2026.07.049

Vancouver

Cozzi O, Tomii D, Lanz J, Thiele H, Heg D, Joner M, et al. Prosthesis–Patient Mismatch and Patient-Centered Outcomes After TAVR. JACC: Cardiovascular Interventions. 2026;19(21):2857-2871. doi:10.1016/j.jcin.2026.07.049

BibTeX
@article{Cozzi2026,
  author = {Cozzi, Ottavia and Tomii, Daijiro and Lanz, Jonas and Thiele, Holger and Heg, Dik and Joner, Michael and Möllmann, Helge and Linke, Axel and Conradi, Lenard and Toggweiler, Stefan and Thilo, Christian and Prendergast, Bernard and Windecker, Stephan and Pilgrim, Thomas and SCOPE I Investigators, SCOPE I Investigators},
  title = {Prosthesis–Patient Mismatch and Patient-Centered Outcomes After TAVR},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {21},
  pages = {2857--2871},
  doi = {10.1016/j.jcin.2026.07.049}
}
Kostenlos starten →